The Insulin in Dosage Market in New Zealand has experienced significant fluctuations over the past decade, starting from a market size of USD 54.772 million in 2013 and growing to USD 81.84 million in 2023. Notably, the market witnessed a substantial dip in 2020, showing a -13.84% year-on-year decrease, but has since rebounded with a cumulative average growth rate (CAGR) of 2.26% over the last five years.
Future trends to watch for:
- Technological advancements in insulin delivery systems and digital health solutions.
- Potential impacts of healthcare policies and funding on insulin accessibility and pricing.
- Growing prevalence of diabetes and obesity, which may further drive demand for insulin products.
How does New Zealand rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 16 | 16 Austria | 97,906,000 | 2023 | +0.53% | +0.26% | View data |
| 17 | 17 Croatia | 84,861,000 | 2023 | +0.79% | -0.044% | View data |
| 18 | 18 New Zealand | 81,840,000 | 2023 | +5.78% | +2.26% | |
| 19 | 19 Slovakia | 72,785,000 | 2023 | -0.13% | +0.52% | View data |
| 20 | 20 Ireland | 58,009,000 | 2023 | -0.15% | -0.85% | View data |
